Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Teligent Pharma, Inc. | Buena, New Jersey, United States | Makes it | Serious problems, FDA actionAug 31, 2021 · 8 inspections, 1 with FDA action |
Recalls
- Jul 29, 2021 · Class II · Teligent Pharma, Inc.
Defective container: possibility for lack of seal integrity.
Lots: Lot #: 14892, Exp 1/2022 - Jun 22, 2021 · Class III · Teligent Pharma, Inc.
Failed Impurities/Degradation Specifications
Lots: Lot 14180
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Erythromycin: every company that makes it
- Form
- solution
- Strength
- 20 mg per 1 mL
- Approval
- ANDA ANDA208100
- On the market since
- Nov 20, 2017
- Package NDCs
52565-027-59- Official label
- DailyMed (National Library of Medicine), updated Nov 20, 2017
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?